Ryan Dick

Ryan Dick is an accomplished professional with extensive experience in drug metabolism and pharmacokinetics (DMPK) within the pharmaceutical industry. Currently serving as Senior Director of DMPK at Maze Therapeutics since January 2019, Ryan previously held significant roles such as Senior Research Scientist at Gilead Sciences, Senior Scientist at MyoKardia and Portola Pharmaceuticals, and Senior Scientist II at Ardea Biosciences. Early career experience includes a position as Senior Research Chemist at Merck and a Postdoctoral Fellowship at UC Berkeley, where research focused on the metabolism of insecticides. Ryan Dick holds a Ph.D. in Pharmacology and Molecular Sciences from The Johns Hopkins University School of Medicine.